Dallas, Texas; Birmingham, Ala.; and Boca Raton, Fla.
From the Department of Plastic Surgery, University of Texas Southwestern Medical Center; the Departments of Dermatology and Ophthalmology, University of Alabama at Birmingham; and Aesthetic Oculoplastic Surgery (private practice).
Received for publication May 1, 2009; accepted September 14, 2009.
Disclosures: Gary Monheit, M.D., is a consultant for Allergan, Dermik, Genzyme, Colbar LifeScience, Contura, Ipsen/Medicis, Stiefel, Melafind, Revance, Kythera, Galderma, and Mentor. None of the other authors has a financial interest regarding the contents of this article.
Rod J. Rohrich, M.D.; Department of Plastic Surgery; University of Texas Southwestern Medical Center; 1801 Inwood Road; Dallas, Texas 75390-9132; firstname.lastname@example.org
Correction: Soft-Tissue Filler Complications: The Important Role of Biofilms
In Figure 2, there is a misspelling in the figure. In the first box in the algorithm, the word “Fluctance” should be “Fluctuance.”
This correction is published in the June 2010 issue of the Journal.